Interestingly, GUHE showed a better promising anticancer effect in exerting a more targeted cytotoxicity impact by selectively inhibiting the proliferation of the OSCC cell lines without harming the HGF cell line as compared with GUME and cisplatin that showed nonselective cytotoxicity against cancer and normal cell lines. This evidence concerns the gene HGF and cancer.